Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1-Reference-Cited by-同舟云学术

Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1

Published:2013-07 Issue:7 Volume:33 Page:1484-1493
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:Arterioscler Thromb Vasc Biol.

Author:

Le May Cédric¹,Berger Jean Mathieu¹,Lespine Anne¹,Pillot Bruno¹,Prieur Xavier¹,Letessier Eric¹,Hussain M. Mahmood¹,Collet Xavier¹,Cariou Bertrand¹,Costet Philippe¹

Affiliation:

1. From the INSERM, UMR 1087, CNRS UMR 6291, Nantes, F-44000 France (C.L.M., J.M.B., B.P., X.P., B.C., P.C.); UMR1331, TOXALIM, INRA, INP, UPS, Toulouse, France (A.L.); Université de Nantes, Nantes, F-44035 France (X.P., B.C.); Department of Endocrine and Visceral Surgery, University Hospital of Nantes, France (E.L.); Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY (M.M.H.); INSERM UMR 1048, Toulouse, France (X.C.); Institut de Maladies Métaboliques et Cardiovasculaires,...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Regulation of Cholesterol Metabolism in the Dog

2. Contribution of newly synthesized cholesterol to rat plasma and bile determined by mass isotopomer distribution analysis: bile-salt flux promotes secretion of newly synthesized cholesterol into bile

3. Failure of Complete Bile Diversion and Oral Bile Acid Therapy in the Treatment of Homozygous Familial Hypercholesterolemia

4. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice

5. Biliary Sterol Secretion Is Not Required for Macrophage Reverse Cholesterol Transport

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P-glycoproteins in anthelmintic safety, efficacy, and resistance;Trends in Parasitology;2024-08

2. PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia;JACC: Basic to Translational Science;2024-08

3. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

4. MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice;Journal of Lipid Research;2024-07

5. Association of lipid-lowering drugs with gut microbiota: A Mendelian randomization study;Journal of Clinical Lipidology;2024-06